LIMILYS Trademark

Trademark Overview

On Thursday, March 3, 2011, a trademark application was filed for LIMILYS with the United States Patent and Trademark Office. The USPTO has given the LIMILYS trademark a serial number of 85257452. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 5, 2015. This trademark is owned by Human Genome Sciences, Inc.. The LIMILYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, nutritional disorders, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation
limilys

General Information

Serial Number85257452
Word MarkLIMILYS
Filing DateThursday, March 3, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 5, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, nutritional disorders, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBRENTFORD, MIDDLESEX TW8 9GS
GB
Party NameGLAXOSMITHKLLNE INTELLECTUAL PROPERTY LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBRENTFORD, MIDDLESEX TW8 9GS
GB
Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, January 5, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 5, 2015ABANDONMENT - NO USE STATEMENT FILED
Friday, May 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 22, 2014EXTENSION 5 GRANTED
Tuesday, May 20, 2014EXTENSION 5 FILED
Tuesday, May 20, 2014TEAS EXTENSION RECEIVED
Wednesday, November 20, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 24, 2013EXTENSION 4 GRANTED
Thursday, October 17, 2013EXTENSION 4 FILED
Thursday, October 17, 2013TEAS EXTENSION RECEIVED
Thursday, June 6, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2013EXTENSION 3 GRANTED
Monday, April 29, 2013EXTENSION 3 FILED
Monday, April 29, 2013TEAS EXTENSION RECEIVED
Wednesday, March 27, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, November 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 2, 2012EXTENSION 2 GRANTED
Wednesday, October 31, 2012EXTENSION 2 FILED
Friday, November 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 31, 2012TEAS EXTENSION RECEIVED
Tuesday, October 23, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 23, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 23, 2012EXTENSION 1 GRANTED
Wednesday, May 23, 2012EXTENSION 1 FILED
Wednesday, May 23, 2012TEAS EXTENSION RECEIVED
Tuesday, November 29, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011PUBLISHED FOR OPPOSITION
Monday, August 29, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, August 28, 2011ASSIGNED TO LIE
Saturday, August 13, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 2, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 7, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 7, 2011NON-FINAL ACTION E-MAILED
Saturday, May 7, 2011NON-FINAL ACTION WRITTEN
Wednesday, May 4, 2011ASSIGNED TO EXAMINER
Tuesday, March 8, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 7, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

limilys diseases disorders conditions joint damage bone transplantation tissue ophthalmologic organ